Single Patient Emergency Use of Lorlatinib for Treatment of Brain Metastases from Lung Cancer with a ROS-1 Mutation
-
- STATUS
- Not Recruiting
Summary
This is a one single patient treatment protocol using the investigational drug Lorlatinib, for a 31 year old patient with lung cancer, (ROS-1 mutation) who experienced disease progression leading to multiple brain metastases while being treated with crizotinib.
Description
This is a one single patient treatment protocol using the investigational drug Lorlatinib, for a 31 year old patient with lung cancer, (ROS-1 mutation) who experienced disease progression leading to multiple brain metastases while being treated with crizotinib.
Details
| Condition | lung cancer |
|---|---|
| Age | 100years or below |
| Clinical Study Identifier | TX7058 |
| Last Modified on | 19 February 2024 |
Similar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.